chr7-35248721-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001077653.2(TBX20):c.501C>T(p.Ser167=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,614,164 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0011 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0013 ( 21 hom. )
Consequence
TBX20
NM_001077653.2 synonymous
NM_001077653.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.354
Genes affected
TBX20 (HGNC:11598): (T-box transcription factor 20) This gene encodes a T-box family member. The T-box family members share a common DNA binding domain, termed the T-box, and they are transcription factors involved in the regulation of developmental processes. This gene is essential for heart development. Mutations in this gene are associated with diverse cardiac pathologies, including defects in septation, valvulogenesis and cardiomyopathy. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 7-35248721-G-A is Benign according to our data. Variant chr7-35248721-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 518497.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-35248721-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.354 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00111 (169/152330) while in subpopulation EAS AF= 0.0205 (106/5172). AF 95% confidence interval is 0.0173. There are 4 homozygotes in gnomad4. There are 87 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 169 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX20 | NM_001077653.2 | c.501C>T | p.Ser167= | synonymous_variant | 3/8 | ENST00000408931.4 | NP_001071121.1 | |
TBX20 | NM_001166220.1 | c.501C>T | p.Ser167= | synonymous_variant | 3/6 | NP_001159692.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX20 | ENST00000408931.4 | c.501C>T | p.Ser167= | synonymous_variant | 3/8 | 1 | NM_001077653.2 | ENSP00000386170 | P1 | |
TBX20 | ENST00000492961.1 | n.512C>T | non_coding_transcript_exon_variant | 3/6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00110 AC: 168AN: 152212Hom.: 4 Cov.: 31
GnomAD3 genomes
AF:
AC:
168
AN:
152212
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00197 AC: 496AN: 251256Hom.: 5 AF XY: 0.00193 AC XY: 262AN XY: 135832
GnomAD3 exomes
AF:
AC:
496
AN:
251256
Hom.:
AF XY:
AC XY:
262
AN XY:
135832
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00125 AC: 1830AN: 1461834Hom.: 21 Cov.: 37 AF XY: 0.00126 AC XY: 913AN XY: 727208
GnomAD4 exome
AF:
AC:
1830
AN:
1461834
Hom.:
Cov.:
37
AF XY:
AC XY:
913
AN XY:
727208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00111 AC: 169AN: 152330Hom.: 4 Cov.: 31 AF XY: 0.00117 AC XY: 87AN XY: 74496
GnomAD4 genome
AF:
AC:
169
AN:
152330
Hom.:
Cov.:
31
AF XY:
AC XY:
87
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 27, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 09, 2023 | - - |
TBX20-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 19, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 01, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at